Table 3.
Clinical data |
N |
miR-877 expression in LC tissues |
P value |
|
---|---|---|---|---|
Low expression (n = 40) High expression (n = 40) | ||||
Age (years) | 0.823 | |||
≤ 65 | 38 | 18 (45.5) | 20 (50.0) | |
> 65 | 42 | 22 (54.5) | 20 (40.0) | |
Gender | 0.622 | |||
Male | 57 | 30 (75.0) | 27 (67.5) | |
Female | 23 | 10 (25.0) | 13 (32.5) | |
Tumor diameter (cm) | 0.999 | |||
≤ 3 | 33 | 17 (42.5) | 16 (40.0) | |
> 3 | 47 | 23 (57.5) | 24 (60.0) | |
Clinical stage | 0.012 | |||
I + II | 34 | 23 (57.5) | 11 (27.5) | |
III + IV | 46 | 17 (42.5) | 29 (72.5) | |
Lymph node metastasis | < 0.001 | |||
No | 48 | 13 (32.5) | 32 (87.5) | |
Yes | 32 | 27 (67.5) | 8 (12.5) | |
Differentiation | < 0.001 | |||
Poor + moderate | 52 | 36 (90.0) | 16 (40.0) | |
High | 28 | 4 (10.0) | 24 (60.0) |
miR-877, microRNA-877; LC, lung cancer.